Disadvantages of these therapies are a lack of specificity and drug resistance. As the majority of these redox-42 related mechanisms also play an important role in successful and coordinated cell functioning and reproduction, 
Different types of reactive oxygen species 71
Reactive oxygen species or ROS are reactive molecules that originate from oxygen as by-products of aerobic 72 metabolism or through enzymatic production [1] [2] [3] [4] (Fig. 1) . Oxygen (O2) in its ground state contains two unpaired 73 electrons with parallel spins (triplet oxygen) and is not that reactive. The excited state of molecular oxygen is 74 singlet oxygen, which is formed via photo-excitation. Singlet oxygen has two electrons with antiparallel spins and 75 forms covalent bonds with other molecules more easily [4, 5] . The superoxide anion radical (°O2 -) is formed after 76 a one-electron reduction of oxygen [3, 6] . This radical functions both as a reductant as well as an oxidant, is short-
77
lived and is not likely to diffuse across the cell membranes, which makes its effects rather localized [6] . When 78 superoxide receives a proton the more reactive hydroperoxyl radical (°HO2) is generated. The two-electron 
172
The enzymatic antioxidant defence system is tightly regulated by various redox-controlled transcription factors,
173
such as the nuclear factor erythroid-2-related factor 2 (Nrf2), the endonuclease 1/redox effector factor 1 
189
NF-κB, a transcription factor playing a crucial role in cell survival, is activated by oxidative stress and in turn
190
activates genes coding for ferritin (FT) and SOD2 [26] .
191
ROS not only activate the antioxidant defence system, they also regulate important processes such as cell 
ROS-(de)regulated processes 209
ROS are important in numerous physiological processes including immunology, wound healing and angiogenesis.
210
However, an imbalance between the production and detoxification of ROS has been linked with ageing and with 211 a broad range of diseases such as cancer, insulin resistance, diabetes mellitus, cardiovascular diseases,
212
atherosclerosis and neurodegenerative conditions [32] . Here, we will focus on redox-related processes within the 213 framework of potential anticarcinogenic targets, the scope of this review. 
223
Moderate damage activates the repair machinery whereafter cell proliferation continues. However, when the DNA
224
damage is irreparable, cell death is initiated [2, 36] . ROS-induced cell death involves both necrosis and apoptosis,
225
depending on the severity of the insult. An important feature in preventing cell death is autophagy, which is 226 activated by ROS and once activated reduces oxidative stress by degrading proteins and damaged mitochondria 227 (mitophagy), a primary source of intracellular ROS [37, 38] . Some DNA regions are more susceptible to ROS-228 induced damage, especially regions rich in guanine bases since different ROS, including singlet oxygen and 229 hydroxyl radicals, convert guanine to 8-oxo-7,8 dihydroguanine resulting in single base DNA damage. Due to 230 their high guanine content, telomeres -the protective and repetitive TTAGGG sequence at the end of the 231 chromosomes -are highly sensitive to ROS. Moreover, in contrast to the majority of the genomic DNA, the repair 232 system of the telomeric region is inefficient in repairing single-stranded breaks. Accelerated degradation of these 233 protective sequences eventually results in destruction of the DNA at the end of the chromosome [39, 40] .
234
Interestingly, overexpression of the telomerase reverse transcriptase (TERT), the catalytic subunit of the 235 telomerase enzyme that elongates the telomeres and is linked with immortalization and stem cell populations,
236
reduces intracellular ROS levels and cell death [41, 42] .
237
Besides inducing cell death through DNA damage, ROS also act as upstream signalling molecules in the induction 
241
Moreover, the expression of antiapoptotic factors, such as Bcl-2 and Bcl-x, is also associated with protection 242 against ROS. During tumour necrosis factor (TNF-α)-induced apoptosis, Bcl-2 prevents the accumulation of ROS 243 and thus the subsequent apoptotic events (mitochondrial membrane depolarization, Bax relocalization, cytochrome 244 c release, caspase activation and nuclear fragmentation). Similarly, Bax and Bcl-x are able to respectively increase 245 or decrease GSH levels, without interfering with other antioxidant enzymes such as SOD, CAT, and GPX/GR [9] .
246

ROS & cell proliferation and differentiation
247
The most important MAPK group via which ROS induce cell proliferation is the ERK family. This 
269
They showed that overexpression of NRX inhibits the expression of early targets of Wnt-signalling whereas NRX 270 knockdown resulted in Wnt pathway activation with reduced expression of anterior markers and structures (e.g.
271
absence of eye development) [44] . In intestinal and colon epithelial cells, NOX1-generated ROS play an essential 
274
ROS & stem cell maintenance
275
Stem cells are characterized by their abilities to self-renew and to produce numerous differentiated progeny cells
276
[49]. The fate of stem cells is (co-)directed by the intra-and extracellular (stem cell niche) redox balance: low
277
ROS levels support stem cell maintenance and quiescence while slightly "higher" ROS levels induce stem cell 278 proliferation and eventually differentiation [1, 42, 50, 51] 
287
Since a precise control of the redox balance is crucial for normal cellular functioning, it is not surprising that any 288 unwanted fluctuations in ROS levels can have devastating outcomes, including the formation of cancer. As ROS 289 are involved in both normal physiological processes as well as in diseases, we will focus on this dual role by 290 emphasizing their importance in two related processes: the physiological process of regeneration and the 291 pathologic process cancer. The role of ROS in both the processes will be discussed in the following sections.
292
ROS modulate carcinogenesis
294
2.1.
ROS as a core component of carcinogenesis 295
Carcinogenesis is characterized by uncontrolled cell divisions, ultimately resulting in a malignant tumour which 
298
DNA damaging effects of ROS are mainly involved in the initiation and progression stage ( 
323
These mutations are for example found in around 50% of colon cancers and up to 90% of pancreatic cancers [59] .
324
Tumour suppressor genes, on the other hand, regulate cell death programs such as apoptosis and, once 325 downregulated or disturbed through mutations, support cell death resistance. The best-known tumour suppressor 326 is undoubtedly p53, which functions in cell cycle arrest, DNA repair, senescence and apoptosis, and is one of the 327 most frequently altered genes in cancer [60] [61] [62] [63] .
328
Apart from DNA damage, ROS also modulate the carcinogenic process via transcriptional and signalling 
355
ROS also play a role in the avoidance of growth suppressor mechanisms, which is another hallmark of cancer. One 356 such mechanism is the suppression of proliferation by contact inhibition, which is believed to be important during 357 wound healing and regeneration, and for which Ras and Ras-induced ROS levels have to be low. Overactivating 
363
Angiogenesis is crucial to maintain continuously-active tumour cells by delivering nutrients and oxygen to the 364 growing cancer and removing waste products and carbon dioxide. In normal physiological processes (e.g. wound 
374
ROS also link tumour-promoting inflammation and cancer. Inflammatory cells produce ROS which attract more 375 inflammatory cells and lead to more ROS production [57] . Chronic inflammation is indeed strongly correlated 
406
The mechanisms by which cancer cells increase ROS are diverse. They activate proto-oncogenes and oncogenes 
424
While elevated ROS levels support tumour initiation, progression and promotion, they also increase the internal 425 stress level and make the tumour more vulnerable to cell death. Therefore, a dynamic ROS regulation in tumour 
469
Moderate hypoxia in the tumour environment also becomes increasingly related to the cancer stem cell phenotype 470 and is thought to be beneficial for the survival, self-renewal and tumour growth of cancer stem cells [1, 100] . In 
476
In conclusion, we can state that it is crucial to determine molecular signalling pathways that maintain the redox 
ROS modulate the regeneration process 480
In the previous section, we summarized the involvement of ROS in tumour initiation, growth and metastasis. To 481 highlight the dual role of ROS, we will also discuss their function in a normal physiological situation, i.e.
482
regeneration. Regeneration and cancer share similar underlying events, but result in a different outcome (section 3.1). As such, we will emphasize the redox-related aspects of the shared processes, among which cell proliferation, 484 apoptosis and differentiation.
485
Regeneration is a complex concept, defined differently depending on the context. 
523
However, this has yet to be confirmed.
524
Apoptosis is a redox-controlled process and Gauron and collegues were the first to link ROS production and the 
534
Both ROS production and innervation seem to be crucial factors to achieve successful regeneration. However,
535
little is known about the crosstalk between both signalling processes [130, 131] . It has been shown that ROS cancer. While they are well coordinated during the regeneration of lost body parts, which is a normal physiological 555 process, the disease cancer is characterized by an uncontrolled execution of these processes and a failure to heal.
556
The initial signals, such as the capacity to sense damage and activate cell proliferation, are most likely unimpaired, 
634
It has long been known that the immune system and inflammation are linked with cancer, but recently more and 635 more research also illustrates the importance of the immune system in the regeneration process [174] [175] [176] [177] [178] 
642
Regeneration and carcinogenesis share many similarities as to redox-controlled processes and mechanisms, yet
643
have different outcomes (Fig. 3) overcome, but also to prevent tumour development (Fig. 3) .
653
Redox-related anticarcinogenic targets in regenerative mechanisms
655
Direct redox-related anticarcinogenic targets 656
The different redox signature of cancer cells and non-cancer cells is an opportunity to selectively target cancer 657 cells with redox-based cancer therapies (Fig. 3) . Both ROS-elevating and -eliminating strategies have been decrease ROS levels by using antioxidants, enhancers of ROS scavenging enzyme activities or NOX inhibitors.
668
They are based on the fact that ROS signalling is important in cancer cell proliferation and that a disturbance of 669 this signalling inhibits tumour growth. Most strategies, however, work through ROS generation and the consequent 670 induction of cell death [1, 33, 85, 183, 184] . Table 1 represents a few of the most described therapeutic procedures 671 of ROS elevating and eliminating strategies, which will be briefly illustrated below. 
690
Besides being used as monotherapy, ROS-generating agents are currently combined with chemo-and radiotherapy 
737
Indirect redox-related anticarcinogenic targets 738
The redox state not only affects cell proliferation, death, and migration directly, it also alters these processes 739 indirectly through the regulation of molecular or systemic pathways. In the following sections, we will focus on 740 the indirect redox-related targets that are promising for anticarcinogenic therapies. 
826
The applied strategy (which signalling factor/pathway should be activated or deactivated) depends on the cancer 
852
provides an indirect pro-oxidant therapeutic intervention [182] . This can be achieved by interfering with the 
860
The metabolism can also be targeted indirectly through alterations in the activity of redox-regulated upstream 
891
Not only the immune system, but also the nervous system is involved in cancer development, as was indicated by 
900
Recent epidemiological data suggest that β-blocker intake is associated with improved survival of prostate cancer 
904
The immune and nervous system are not only involved in carcinogenesis, they also come forward as important 
944
Another defence mechanism of cancer stem cells is the expression of multidrug resistance ABC transporters that 
961
Finally, the preferential activation of the DNA damage checkpoint response and increased DNA repair capacity 962 which can diminish therapy-induced ROS damage is thought to increase the radioresistance of cancer stem cells.
963
An inhibition of the Chk1 and Chk2 checkpoint kinases for example reversed the radioresistance of CD133+ 
